Peripheral Artery Questionnaire Released
22 November 2004 - 08:01
CV Outcomes is pleased to provide licensing opportunities for the Peripheral Artery Questionnaire. The PAQ is a disease-specific health status measure for patients with peripheral arterial disease. Like the Seattle Angina Questionnaire and the Kansas City Cardiomyopathy Questionnaire, the PAQ has been rigorously tested to demonstrate its validity, reliability and responsiveness. For a disease such as peripheral arterial disease, in which the primary goal of treatment is to improve patients’ symptoms, function and quality of life, it is hoped that the PAQ can serve as a primary endpoint in clinical trials, as a marker of severely affected patients requiring treatment and as a tool for improving the quality and follow-up of treated patients.
The PAQ was co-developed by Dr. John Spertus, Director of Outcomes Research at the Mid America Heart Institute, and Dr. Krishna Rocha-Singh, an interventional Cardiologist at the Prairie Heart Institute in Springfield Illinois. Leveraging their combined extensive methodological and clinical expertise, they were able to significantly advance the quality of outcomes assessment in this growing population of patients. The PAQ is currently being used in several observational registries and clinical trials.